Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

TELO Telomir Pharmaceuticals

盘后交易 07-06 16:22:46 EDT

1.27

+0.00

0.00%

盘后1.25

-0.02-1.57%

16:14 EDT

最高1.29	最低1.25	成交量3.54万
今开1.29	昨收1.27	日振幅3.15%
总市值8,734万	流通市值5,780万	总股本6,878万
成交额4.52万	换手率0.08%	流通股本4,551万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"TELO","market":"US","secType":"STK","nameCN":"Telomir Pharmaceuticals","latestPrice":1.27,"timestamp":1783368000000,"preClose":1.27,"halted":0,"volume":35416,"hourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.27,"latestTime":"16:14 EDT","volume":809,"amount":1011.4299216,"timestamp":1783368898821,"change":-0.02,"changeRate":-0.015748,"amplitude":0.015748},"delay":0,"changeRate":0,"floatShares":45513713,"shares":68775000,"eps":-0.281163,"marketStatus":"盘后交易","change":0,"latestTime":"07-06 16:22:46 EDT","open":1.29,"high":1.29,"low":1.25,"amount":45164,"amplitude":0.031496,"askPrice":1.43,"askSize":200,"bidPrice":1.25,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-0.281163,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1783382400000},"marketStatusCode":4,"adr":0,"listingDate":1707454800000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.27,"latestTime":"09:23 EDT","volume":692,"amount":904.2256047999999,"timestamp":1783344180577,"change":0.03,"changeRate":0.023622,"amplitude":0.029606},"postHourTrading":{"tag":"盘后","latestPrice":1.25,"preClose":1.27,"latestTime":"16:14 EDT","volume":809,"amount":1011.4299216,"timestamp":1783368898821,"change":-0.02,"changeRate":-0.015748,"amplitude":0.015748},"volumeRatio":0.540711},"requestUrl":"/m/hq/s/TELO","defaultTab":"news","newsList":[{"id":"1181559527","title":"Telomir Pharmaceuticals任命安德里·穆沙克为兼职首席财务官，2026年6月6日生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1181559527","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181559527?lang=zh_cn&edition=full","pubTime":"2026-06-09 05:03","pubTimestamp":1780952595,"startTime":"0","endTime":"0","summary":"根据一份提交给美国证券交易委员会的文件，生物制药公司Telomir Pharmaceuticals已正式任命安德里·穆沙克为其兼职首席财务官，此项任命将于2026年6月6日正式生效。\n此项人事任命标志着该公司在加强其财务管理团队方面迈出了关键一步。穆沙克先生将以其丰富的财务专业经验，为公司的战略发展提供支持。\n公司此举旨在优化其财务架构，以更好地适应未来的业务拓展与研发需求。市场观察人士将密切关注此次高层变动对公司运营及长期财务表现可能产生的影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104053534","title":"Telomir Pharmaceuticals计划于2026年上半年启动Telomir-Zn的I/II期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1104053534","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104053534?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:22","pubTimestamp":1777551733,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的最新文件，Telomir Pharmaceuticals Inc已明确规划，将在2026年上半年正式启动其核心候选药物Telomir-Zn的I/II期临床试验。这一关键进展标志着公司在新药研发道路上迈出了实质性的一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147882713","title":"Telomir Pharmaceuticals向FDA提交Telomir-1 (Telomir-Zn)用于治疗晚期及转移性三阴性乳腺癌的新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1147882713","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147882713?lang=zh_cn&edition=full","pubTime":"2026-03-31 19:09","pubTimestamp":1774955356,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals已正式向美国食品药品监督管理局提交了其候选药物Telomir-1（亦称为Telomir-Zn）的新药临床试验申请。该申请旨在评估该药物在治疗晚期及转移性三阴性乳腺癌患者中的潜力。这一进展标志着公司在推进其创新疗法方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141059435","title":"铁拯救实验证实：Telomir Pharmaceuticals肿瘤细胞死亡由机制驱动，非特异性细胞毒性","url":"https://stock-news.laohu8.com/highlight/detail?id=1141059435","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141059435?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:13","pubTimestamp":1771333991,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals公司的最新研究取得关键进展。其铁拯救实验明确证实，所观察到的肿瘤细胞死亡现象是由特定机制驱动，而非非特异性细胞毒性作用。这一发现为该公司抗癌疗法的精准作用机制提供了有力证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121596533","title":"Telomir Pharmaceuticals 在人类三阴性乳腺癌模型中展现广泛肿瘤细胞杀伤力","url":"https://stock-news.laohu8.com/highlight/detail?id=1121596533","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121596533?lang=zh_cn&edition=full","pubTime":"2026-02-17 21:13","pubTimestamp":1771333990,"startTime":"0","endTime":"0","summary":"Telomir Pharmaceuticals Inc 最新研究显示，该公司在人类三阴性乳腺癌实验模型中实现了广泛的肿瘤细胞死亡率。这一突破性进展为治疗这种侵袭性乳腺癌亚型带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112118530","title":"Telomir Pharmaceuticals：Telomir-1在侵袭性三阴性乳腺癌动物模型中显著抑制肿瘤生长与转移","url":"https://stock-news.laohu8.com/highlight/detail?id=1112118530","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112118530?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:08","pubTimestamp":1767618492,"startTime":"0","endTime":"0","summary":"在针对侵袭性三阴性乳腺癌的临床前研究中，Telomir Pharmaceuticals公司研发的候选药物Telomir-1展现出令人瞩目的抗肿瘤活性。实验数据显示，该药物能显著减缓肿瘤的生长速度，并有效抑制癌细胞的远端转移。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517604549","title":"Telomir Pharmaceuticals, Inc.盘中异动 急速下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517604549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517604549?lang=zh_cn&edition=full","pubTime":"2025-03-05 01:01","pubTimestamp":1741107718,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日01时01分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.11%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305010159a25f2dcd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305010159a25f2dcd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514330909","title":"Telomir Pharmaceuticals, Inc.盘中异动 临近收盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330909","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330909?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:58","pubTimestamp":1740689885,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时58分，Telomir Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.10%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280458069632f6da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280458069632f6da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514015502","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.66%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514015502?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:14","pubTimestamp":1740496471,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时14分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.66%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Gt Biopharma, Inc.、Moleculin Biotech, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1047.09%、584.79%、542.75%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Silexion Therapeutics Corp、Gri Bio, Inc.，振幅分别为63.66%、61.16%、56.51%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252314329892566e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252314329892566e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727952","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727952?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407485,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.14%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231269890f572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242231269890f572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513921960","title":"Telomir Pharmaceuticals, Inc.盘中异动 下午盘急速下跌5.02%报3.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513921960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513921960?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:02","pubTimestamp":1740164575,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时02分，Telomir Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.02%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家领先的临床前阶段制药公司，引领着年龄逆转科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎和其他疾病进行临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030255988e1713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030255988e1713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512433911","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512433911","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512433911?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:31","pubTimestamp":1739989893,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时31分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.36%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023133988b57db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220023133988b57db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512416526","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.36%报4.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512416526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512416526?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:35","pubTimestamp":1739889322,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时35分，Telomir Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.36%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235229889fd78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182235229889fd78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510328893","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨6.18%报4.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510328893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510328893?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:36","pubTimestamp":1739208979,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日01时36分，Telomir Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.18%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Biodexa Pharmaceuticals Plc、Dominari Holdings Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2983.07%、1609.33%、1188.57%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Abpro Holdings Inc C/Wts 12/11/2029 、Ocean Biomedical, Inc.，振幅分别为99.86%、87.80%、85.48%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101361998809c05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021101361998809c05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508142502","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142502","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142502?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:17","pubTimestamp":1738595825,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时17分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.35%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231705abc1112d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231705abc1112d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507666269","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.09%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507666269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507666269?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:43","pubTimestamp":1738334637,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时43分，Telomir Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.09%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312243579614ec9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312243579614ec9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506585865","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大跌5.57%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506585865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506585865?lang=zh_cn&edition=full","pubTime":"2025-01-28 02:22","pubTimestamp":1738002153,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日02时22分，Telomir Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.57%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.77%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802223396125b97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012802223396125b97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506894121","title":"Telomir Pharmaceuticals, Inc.盘中异动 股价大涨6.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506894121?lang=zh_cn&edition=full","pubTime":"2025-01-25 03:01","pubTimestamp":1737745297,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日03时01分，Telomir Pharmaceuticals, Inc.股票出现异动，股价快速拉升6.32%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。通过在细胞层面解决衰老的根本原因，Telomir旨在解决这些疾病的根源，而不仅仅是治疗症状。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030137abb788c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125030137abb788c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TELO","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505010952","title":"Telomir Pharmaceuticals, Inc.盘中异动 早盘大幅跳水5.12%报4.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505010952","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505010952?lang=zh_cn&edition=full","pubTime":"2025-01-23 23:44","pubTimestamp":1737647047,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日23时44分，Telomir Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.12%。Telomir Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Telomir Pharmaceuticals, Inc.公司简介：Telomir Pharmaceuticals Inc是一家处于临床前阶段的先锋制药公司，引领抗衰老科学的发展。Telomir正在对早衰症、糖尿病、癌症、阿尔茨海默病、骨关节炎等进行持续的临床前研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123234407abb60a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123234407abb60a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TELO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telomirpharma.com","stockEarnings":[{"period":"1week","weight":0.0325},{"period":"1month","weight":0.0242},{"period":"3month","weight":0},{"period":"6month","weight":-0.0522},{"period":"1year","weight":0.0763},{"period":"ytd","weight":-0.0451}],"compareEarnings":[{"period":"1week","weight":0.0143},{"period":"1month","weight":-0.0195},{"period":"3month","weight":0.1356},{"period":"6month","weight":0.0902},{"period":"1year","weight":0.2004},{"period":"ytd","weight":0.0922}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Telomir Pharmaceuticals, Inc.于2021年8月成立为佛罗里达州的一家公司。该公司是一家临床前阶段制药公司，专注于TELOMIR-1的开发和商业化，TELOMIR-1是一种正在开发的新型小分子，可作为人类干细胞的口服原位治疗性治疗。原位干细胞疗法利用人体的自然资源来再生受损组织，并用新的功能性细胞取代细胞。","exchange":"NASDAQ","name":"Telomir Pharmaceuticals","nameEN":"Telomir Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Telomir Pharmaceuticals,TELO,Telomir Pharmaceuticals股票,Telomir Pharmaceuticals股票老虎,Telomir Pharmaceuticals股票老虎国际,Telomir Pharmaceuticals行情,Telomir Pharmaceuticals股票行情,Telomir Pharmaceuticals股价,Telomir Pharmaceuticals股市,Telomir Pharmaceuticals股票价格,Telomir Pharmaceuticals股票交易,Telomir Pharmaceuticals股票购买,Telomir Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Telomir Pharmaceuticals(TELO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Telomir Pharmaceuticals(TELO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}